Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops

Author(s):  Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole

Issue:  Nov/Dec 2009 - Geriatric Compounding
View All Articles in Issue

Page(s):  540-543

Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Page 1
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Page 2
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Page 3
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Page 4

Download in electronic PDF format for $65

Abstract:  Severe dry eye syndrome can adversely affect a patient’s quality of life. When preservative-free artificial tear solutions are not adequate to reduce symptoms, the patient’s own serum can be compounded into eye drops that improve the ocular surface. The aim of our study was to test the sterility of autologous serum eye drops in refrigerator conditions for up to 30 days and in freezer conditions for up to 180 days. It was determined that sterility was maintained throughout this period.

Related Keywords: Dana Reed-Kane, PharmD, FIACP, FACA, NFPPhC, FCP, Rachel A. Carlson, Thomas C. Kupiec, PhD, Nicole Vu, PhD, dry eye, autologous serum eye drops, ocular irritation, eye disorders, stability, sterile preparations, clinical testing, ophthalmic preparations

Related Categories: OPHTHALMICS, STERILE PREPARATIONS, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana
, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009
Pg. 540-543

Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William
, Angelle Patricea (Patsy), Chang Richard I
Nov/Dec 2009
Pg. 506-515

Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis
, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
May/Jun 2015
Pg. 252-260

Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Robert Marie-Claude
, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Sep/Oct 2014
Pg. 418-426

Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves
, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022
Pg. 336-341

Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill
, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014
Pg. 370-377

Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
Jul/Aug 2013
Pg. 307-311

Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%
Berisa Prado Silvia
, Riestra Ayora Ana Cristina, Trelles Campa Adrián
Sep/Oct 2019
Pg. 418-421

Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole
, Lou Jessica R, Kupiec Thomas C
Jul/Aug 2014
Pg. 305-310

Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions